MYCi975
| CAS No. | 2289691-01-4 | Cat. No. | BCP34062 |
| Name | MYCi975 | ||
| Synonyms | MYCi-975;MYCi 975;NUCC-0200975;NUCC 0200975;NUCC0200975; | ||
| Formula | C25H16Cl2F6N2O2 | M. Wt | 561.30 |
| Description | MYCi975 is an orally active MYC inhibitor, which disrupts MYC/MAX interaction, promotes MYC T58 phosphorylation and MYC degradation, and impairs MYC driven gene expression. MYCi975 (NUCC-0200975) exhibits potent anti-tumor efficacy with good tolerability, increases tumor immune cell infiltration, and sensitizes tumors to anti-PD1 immunotherapy. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | c Myc | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.